Duch, P., Díaz Valdivia, N., Ikemori, R., Gabasa Ferràndez, M., Radisky, E. S., Arshakyan, M., . . . Alcaraz Casademunt, J. (2022). Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma.
Citación estilo ChicagoDuch, Paula, et al. Aberrant TIMP-1 Overexpression in Tumor-associated Fibroblasts Drives Tumor Progression Through CD63 in Lung Adenocarcinoma. 2022.
Cita MLADuch, Paula, et al. Aberrant TIMP-1 Overexpression in Tumor-associated Fibroblasts Drives Tumor Progression Through CD63 in Lung Adenocarcinoma. 2022.
Precaución: Estas citas no son 100% exactas.